Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 10, 2022
Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort: A population-based cohort study in the Netherlands using the PHARMO Database NetworkJosephina G Kuiper, Jetty A Overbeek, Caroline Foch, et al.
BMC Nephrology|November 14, 2023
Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complicationsMarc G Vervloet, Hilda Ji de Jong, Jan Pander, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 24, 2023
[Prevalence and drug treatment of people with type 2 diabetes mellitus and a very high risk of cardiovascular disease]Erik H Serné, Jetty A Overbeek, Jan Palmen, et al.
Human Psychopharmacology|June 15, 2016
Post authorization safety study comparing quetiapine to risperidone and olanzapineEdith M Heintjes, Jetty A Overbeek, Fernie J A Penning-van Beest, et al.
Clinical Therapeutics|November 8, 2017
Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European CountriesEdith M Heintjes, Jetty A Overbeek, Gillian C Hall, et al.
British Journal of Clinical Pharmacology|September 27, 2021
Infliximab use in the Netherlands: Uptake and characteristics of originator and biosimilars over timeJetty A Overbeek, Josephina G Kuiper, Marina Bakker, et al.
Clinical Epidemiology|January 13, 2023
Completeness and Representativeness of the PHARMO General Practitioner (GP) Data: A Comparison with National StatisticsJetty A Overbeek, Karin M A Swart, Eline Houben, et al.
British Journal of Clinical Pharmacology|March 18, 2025
General practitioner consultation for postmenopausal bleeding after COVID-19 vaccination-a self-controlled cohort studyRana Jajou, Eugène P van Puijenbroek, Renee Veldkamp, et al.
Acta Ophthalmologica|May 12, 2017
Ophthalmic nepafenac use in the Netherlands and DenmarkAndrea V Margulis, Eline Houben, Jesper Hallas, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 23, 2023
Impact of implementing Dutch versus European guideline risk factor targets in older patients with ischaemic heart diseaseTinka J van Trier, Marjolein Snaterse, Ron M C Herings, et al.
Pageof 5